Form 8-K - Current report:
SEC Accession No. 0001193125-26-148865
Filing Date
2026-04-09
Accepted
2026-04-09 07:13:22
Documents
33
Period of Report
2026-04-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d147019d8k.htm   iXBRL 8-K 26414
2 EX-99.1 d147019dex991.htm EX-99.1 32096
3 EX-99.2 d147019dex992.htm EX-99.2 26575
7 GRAPHIC g147019dsp010.jpg GRAPHIC 137049
8 GRAPHIC g147019dsp011.jpg GRAPHIC 551806
9 GRAPHIC g147019dsp012.jpg GRAPHIC 75007
10 GRAPHIC g147019dsp013.jpg GRAPHIC 281059
11 GRAPHIC g147019dsp014.jpg GRAPHIC 234809
12 GRAPHIC g147019dsp015.jpg GRAPHIC 231196
13 GRAPHIC g147019dsp016.jpg GRAPHIC 214908
14 GRAPHIC g147019dsp017.jpg GRAPHIC 179247
15 GRAPHIC g147019dsp018.jpg GRAPHIC 205495
16 GRAPHIC g147019dsp019.jpg GRAPHIC 125075
17 GRAPHIC g147019dsp020.jpg GRAPHIC 340112
18 GRAPHIC g147019dsp021.jpg GRAPHIC 259606
19 GRAPHIC g147019dsp022.jpg GRAPHIC 241872
20 GRAPHIC g147019dsp023.jpg GRAPHIC 296315
21 GRAPHIC g147019dsp024.jpg GRAPHIC 264672
22 GRAPHIC g147019dsp025.jpg GRAPHIC 183935
23 GRAPHIC g147019dsp026.jpg GRAPHIC 113639
24 GRAPHIC g147019dsp027.jpg GRAPHIC 104934
25 GRAPHIC g147019dsp028.jpg GRAPHIC 112270
26 GRAPHIC g147019dsp4.jpg GRAPHIC 3735
  Complete submission text file 0001193125-26-148865.txt   5921048

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ivvd-20260409.xsd EX-101.SCH 2836
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivvd-20260409_lab.xml EX-101.LAB 17976
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivvd-20260409_pre.xml EX-101.PRE 11248
36 EXTRACTED XBRL INSTANCE DOCUMENT d147019d8k_htm.xml XML 3621
Mailing Address 209 CHURCH STREET NEW HAVEN CT 06510
Business Address 209 CHURCH STREET NEW HAVEN CT 06510 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 26849800
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)